Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › AVLN

DEERFIELD MANAGEMENT COMPANY, L.P. position in AVLN

AVALYN PHARMACEUTICALS INC · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 731,000 shares of AVLN (AVALYN PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$20.8M, representing 0.42% of its reported portfolio and ranking #49 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)731.00K sh
Reported value held$20.83M
Portfolio Weight0.42%
First reportedQ2 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s AVLN position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in AVLN in Q2 2026 at 731,000 shares (US$24.1M). Across 2 filings, DEERFIELD MANAGEMENT COMPANY, L.P. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 731,000 shares valued at US$20.8M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 731.00K $24.06M New
Q3 2026 731.00K $20.83M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVLN and 13F data

AVLN (AVALYN PHARMACEUTICALS INC) is a Health Care company. 114 other funds we track also report a position in AVLN — the largest reported positions include Novo Holdings A/S (US$98.3M), SR ONE CAPITAL MANAGEMENT, LP (US$94.3M), PERCEPTIVE ADVISORS LLC (US$76.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVLN

All AVLN fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held AVLN?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in AVLN?

As of Q3 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 731.00K shares of AVLN (AVALYN PHARMACEUTICALS INC), valued at $20.83M, representing 0.42% of its reported portfolio and ranking #49.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling AVLN?

In the latest 13F filing (Q3 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in AVLN.

Which other funds hold AVLN?

Other major institutional holders of AVLN include Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, among 114 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.